Characterization of in vivo chemoresistant human hepatocellular carcinoma cells with transendothelial differentiation capacities

BMC Cancer

Volumn 13, Issue , 2013, Pages

  Marfels, Christian ^a   Hoehn, Miriam ^a   Wagner, Ernst ^a   Günther, Michael ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

Cancer stemness; Chemoresistance; Cyclophosphamide; Tumor plasticity

Indexed keywords

ALDEHYDE DEHYDROGENASE; ALDEHYDE DEHYDROGENASE ISOENZYME 1; CD31 ANTIGEN; CYCLOPHOSPHAMIDE; INTERCELLULAR ADHESION MOLECULE 1; MESSENGER RNA; NOTCH1 RECEPTOR; NOTCH3 RECEPTOR; OCTAMER TRANSCRIPTION FACTOR 4; THY 1 ANTIGEN; TRANSCRIPTION FACTOR HES 1; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RESISTANCE; CELL TRANSDIFFERENTIATION; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; LIVER CELL CARCINOMA; MALE; METRONOMIC DRUG ADMINISTRATION; MOUSE; NONHUMAN; PLURIPOTENT STEM CELL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSENDOTHELIAL DIFFERENTIATION; TUMOR CELL; TUMOR SPHEROID; TUMOR VASCULARIZATION; TUMOR XENOGRAFT; UPREGULATION;

ADMINISTRATION, METRONOMIC; ANIMALS; ANTIGENS, THY-1; ANTINEOPLASTIC AGENTS; BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL TRANSDIFFERENTIATION; DISEASE MODELS, ANIMAL; DRUG RESISTANCE, NEOPLASM; ENDOTHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; HOMEODOMAIN PROTEINS; HUMANS; ISOENZYMES; LIVER NEOPLASMS; MALE; MICE; NEOVASCULARIZATION, PATHOLOGIC; OCTAMER TRANSCRIPTION FACTOR-3; RECEPTOR, NOTCH1; RETINAL DEHYDROGENASE; SOXB1 TRANSCRIPTION FACTORS; SPHEROIDS, CELLULAR; TUMOR CELLS, CULTURED; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84875482297     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-13-176     Document Type: Article

References (28)

1. Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer 2006, 6:674-687. 10.1038/nrc1934, 16929323.
2. Pang R, Poon RT. Angiogenesis and antiangiogenic therapy in hepatocellular carcinoma. Cancer Lett 2006, 242:151-167. 10.1016/j.canlet.2006.01.008, 16564617.
3. Finn RS, Zhu AX. Targeting angiogenesis in hepatocellular carcinoma: focus on VEGF and bevacizumab. Expert Rev Anticancer Ther 2009, 9:503-509. 10.1586/era.09.6, 19374603.
4. Llovet JM, Ricci S, Mazzaferro V, Hilgard P, Gane E, Blanc JF, de Oliveira AC, Santoro A, Raoul JL, Forner A, Schwartz M, Porta C, Zeuzem S, Bolondi L, Greten TF, Galle PR, Seitz JF, Borbath I, Haussinger D, Giannaris T, Shan M, Moscovici M, Voliotis D, Bruix J. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med 2008, 359:378-390. 10.1056/NEJMoa0708857, 18650514.
5. Park ST, Jang JW, Kim GD, Park JA, Hur W, Woo HY, Kim JD, Kwon JH, Yoo CR, Bae SH, Choi JY, Yoon SK. Beneficial effect of metronomic chemotherapy on tumor suppression and survival in a rat model of hepatocellular carcinoma with liver cirrhosis. Cancer Chemother Pharmacol 2009, 65:1029-1037.
6. Browder T, Butterfield CE, Kraling BM, Shi B, Marshall B, O'Reilly MS, Folkman J. Antiangiogenic scheduling of chemotherapy improves efficacy against experimental drug-resistant cancer. Cancer Res 2000, 60:1878-1886.
7. Folkman J. Angiogenesis. Annu Rev Med 2006, 57:1-18. 10.1146/annurev.med.57.121304.131306, 16409133.
8. Broxterman HJ, Lankelma J, Hoekman K. Resistance to cytotoxic and anti-angiogenic anticancer agents: similarities and differences. Drug Resist Updat 2003, 6:111-127. 10.1016/S1368-7646(03)00026-8, 12860459.
9. Emmenegger U, Shaked Y, Man S, Bocci G, Spasojevic I, Francia G, Kouri A, Coke R, Cruz-Munoz W, Ludeman SM, Colvin OM, Kerbel RS. Pharmacodynamic and pharmacokinetic study of chronic low-dose metronomic cyclophosphamide therapy in mice. Mol Cancer Ther 2007, 6:2280-2289. 10.1158/1535-7163.MCT-07-0181, 17671082.
10. Thoenes L, Hoehn M, Kashirin R, Ogris M, Arnold GJ, Wagner E, Guenther M. In vivo chemoresistance of prostate cancer in metronomic cyclophosphamide therapy. J Proteomics 2010, 73:1342-1354. 10.1016/j.jprot.2010.02.019, 20219715.
11. Gunther M, Waxman DJ, Wagner E, Ogris M. Effects of hypoxia and limited diffusion in tumor cell microenvironment on bystander effect of P450 prodrug therapy. Cancer Gene Ther 2006, 13:771-779. 10.1038/sj.cgt.7700955, 16543915.
12. Abe T, Tada M, Shinohara N, Okada F, Itoh T, Hamada J, Harabayashi T, Chen Q, Moriuchi T, Nonomura K. Establishment and characterization of human urothelial cancer xenografts in severe combined immunodeficient mice. Int J Urol 2006, 13:47-57. 10.1111/j.1442-2042.2006.01220.x, 16448432.
13. Mueller MM, Peter W, Mappes M, Huelsen A, Steinbauer H, Boukamp P, Vaccariello M, Garlick J, Fusenig NE. Tumor progression of skin carcinoma cells in vivo promoted by clonal selection, mutagenesis, and autocrine growth regulation by granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor. Am J Pathol 2001, 159:1567-1579. 10.1016/S0002-9440(10)62541-2, 1850484, 11583982.
14. Gu G, Yuan J, Wills M, Kasper S. Prostate cancer cells with stem cell characteristics reconstitute the original human tumor in vivo. Cancer Res 2007, 67:4807-4815. 10.1158/0008-5472.CAN-06-4608, 17510410.
15. Zhang S, Balch C, Chan MW, Lai HC, Matei D, Schilder JM, Yan PS, Huang TH, Nephew KP. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res 2008, 68:4311-4320. 10.1158/0008-5472.CAN-08-0364, 2553722, 18519691.
16. Hay DC, Sutherland L, Clark J, Burdon T. Oct-4 knockdown induces similar patterns of endoderm and trophoblast differentiation markers in human and mouse embryonic stem cells. Stem Cells 2004, 22:225-235. 10.1634/stemcells.22-2-225, 14990861.
17. Boyer LA, Lee TI, Cole MF, Johnstone SE, Levine SS, Zucker JP, Guenther MG, Kumar RM, Murray HL, Jenner RG, Gifford DK, Melton DA, Jaenisch R, Young RA. Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 2005, 122:947-956. 10.1016/j.cell.2005.08.020, 3006442, 16153702.
18. Lu JW, Chang JG, Yeh KT, Chen RM, Tsai JJ, Hu RM. Overexpression of Thy1/CD90 in human hepatocellular carcinoma is associated with HBV infection and poor prognosis. Acta Histochem 2011, 113:833-838. 10.1016/j.acthis.2011.01.001, 21272924.
19. Chadwick N, Zeef L, Portillo V, Fennessy C, Warrander F, Hoyle S, Buckle AM. Identification of novel Notch target genes in T cell leukaemia. Mol Cancer 2009, 8:35. 10.1186/1476-4598-8-35, 2698846, 19508709.
20. Kageyama R, Ohtsuka T, Tomita K. The bHLH gene Hes1 regulates differentiation of multiple cell types. Mol Cells 2000, 10:1-7. 10.1007/s10059-000-0001-0, 10774739.
21. Lawson ND, Scheer N, Pham VN, Kim CH, Chitnis AB, Campos-Ortega JA, Weinstein BM. Notch signaling is required for arterial-venous differentiation during embryonic vascular development. Development 2001, 128:3675-3683.
22. Lawson ND, Vogel AM, Weinstein BM. Sonic hedgehog and vascular endothelial growth factor act upstream of the Notch pathway during arterial endothelial differentiation. Dev Cell 2002, 3:127-136. 10.1016/S1534-5807(02)00198-3, 12110173.
23. Grant DS, Tashiro K, Segui-Real B, Yamada Y, Martin GR, Kleinman HK. Two different laminin domains mediate the differentiation of human endothelial cells into capillary-like structures in vitro. Cell 1989, 58:933-943. 10.1016/0092-8674(89)90945-8, 2528412.
24. Basu GD, Liang WS, Stephan DA, Wegener LT, Conley CR, Pockaj BA, Mukherjee P. A novel role for cyclooxygenase-2 in regulating vascular channel formation by human breast cancer cells. Breast Cancer Res 2006, 8:R69. 10.1186/bcr1626, 1797025, 17156488.
25. Scavelli C, Nico B, Cirulli T, Ria R, Di Pietro G, Mangieri D, Bacigalupo A, Mangialardi G, Coluccia AM, Caravita T, Molica S, Ribatti D, Dammacco F, Vacca A. Vasculogenic mimicry by bone marrow macrophages in patients with multiple myeloma. Oncogene 2008, 27:663-674. 10.1038/sj.onc.1210691, 17667938.
26. El Hallani S, Boisselier B, Peglion F, Rousseau A, Colin C, Idbaih A, Marie Y, Mokhtari K, Thomas JL, Eichmann A, Delattre JY, Maniotis AJ, Sanson M. A new alternative mechanism in glioblastoma vascularization: tubular vasculogenic mimicry. Brain 2010, 133:973-982. 10.1093/brain/awq044, 20375132.
27. Bussolati B, Grange C, Sapino A, Camussi G. Endothelial cell differentiation of human breast tumour stem/progenitor cells. J Cell Mol Med 2009, 13:309-319. 10.1111/j.1582-4934.2008.00338.x, 3087118, 18410528.
28. Bruno S, Bussolati B, Grange C, Collino F, Graziano ME, Ferrando U, Camussi G. CD133+ renal progenitor cells contribute to tumor angiogenesis. Am J Pathol 2006, 169:2223-2235. 10.2353/ajpath.2006.060498, 1762463, 17148683.